Gururaj Shan, MD

Weill Cornell Medicine is a premier healthcare provider affiliated with NewYork-Presbyterian Hospital, dedicated to delivering exceptional and compassionate patient care. The organization offers a range of services, including virtual health options, patient education, and clinical trials, ensuring comprehensive support for patients' needs. With a commitment to advancing medical research and education, Weill Cornell Medicine fosters the development of exceptional doctors and scientists while maintaining a focus on individualized patient care. Their dedication to innovation is reflected in pioneering health initiatives and a high patient satisfaction score. Generated from the website

POSITIONS:Mark W. Pasmantier Professor of Hematology and Medical Oncology in MedicineDirector of NewYork-Presbyterian Hospital - Weill Cornell Medicine Healthcare Systems Cancer ProgramAssociate Director for Clinical Services, Sandra and Edward Meyer Cancer Center at Weill Cornell MedicinePROFESSIONAL TRAINING:Intern, Internal Medicine, University of Wisconsin Hospital & Clinics, Madison, Wisconsin, 1982-83Resident, Internal Medicine, Albert Einstein College of Medicine, Bronx, New York, 1983-85Clinical Fellow, Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, 1985-89Dr. Nanus is an internationally recognized leader in the treatment and care of patients with genitourinary (GU) cancers, including cancers of the prostate, kidney, bladder and testes. He is actively involved in clinical, translational and basic research in GU malignancies, serving as principle or co-investigator on a variety of clinical research trials that incorporate novel targeted therapies for his patients.Dr. Nanus served as Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine for 14 years prior to becoming the Director of the NewYork-Presbyterian Hospital and Weill Cornell Medicine Healthcare Systems Cancer Program. Dr. Nanus is also the Associate Director of Clinical Services for the Sandra and Edward Meyer Cancer Center. He is the recipient of numerous awards including membership in the American Society for Clinical Investigation and the American Association of Physicians.Dr. Nanus is a graduate of the University of Illinois and the Chicago Medical School at the Rosalind Franklin University of Medicine and Science. After completing clinical training in Medicine at Albert Einstein and Medical Oncology at Memorial Sloan Kettering Cancer Center, and research training at the Sloan Kettering Institute, he was invited to join the faculty at Memorial Sloan Kettering Cancer Center in 1989. Developing a program in GU cancer, he made several important contributions to clinical and basic research in kidney and prostate cancer. He was recruited to the full-time faculty of Weill Cornell Medical College in 1998.At Weill Cornell, Dr. Nanus helped develop the Genitourinary (GU) Oncology Research Program focused on understanding the events that contribute to the progression of urologic cancers, and on developing new and more effective therapies to treat advanced prostate, kidney and bladder cancer. As a Director of the Genitourinary Oncology Research Laboratory, he works with a unique interdepartmental team of world class clinical researchers seeking to translate research on the molecular basis of GU cancers into improved cancer treatment.

Weill Cornell Medicine Plastic and Reconstructive Surgery is part of the prestigious Weill Cornell Medicine organization, affiliated with NewYork-Presbyterian Hospital, dedicated to delivering exceptional patient care with compassion and expertise. Offering a wide range of clinical and digital health services, the institution focuses on addressing the needs of patients through innovative treatments and a commitment to individualized care. With a notable satisfaction score and numerous locations throughout New York, Weill Cornell Medicine's team of over 2,000 doctors emphasizes patient safety and education, ensuring that patients receive comprehensive care and support. Their commitment to advancing medical knowledge is reflected in their participation in clinical trials and ongoing research efforts. Generated from the website